| Wednesday, 29/October/2025 | AhmadiNia Hall | |||
| Invasive management for pulmonary emboli; where are we? A case-based discussion | ||||
| 8:30-10:00 | Learning Objectives | · Brief Review of Clinical Prediction, Risk Stratification and Management of Pulmonary Emboli through:
1. Discuss the latest evidence on the invasive management of acute PE 2. A to Z of PE CDT via a live-in-box presentation 3. Future direction |
||
| Moderators: | Sadeghipour P, MD. Mohebbi B, MD. | |||
| Panelists: | Moosavi J, MD. Rashidi F, MD. Sharif Kashani B, MD. Shafe O, MD. Shirvani E, MD. Vojdanparast M, MD. | |||
| 8:30-8:33 | Introduction
Mohebbi B, MD. |
|||
| 8:33-8:35 | Objective
Sadeghipour P, MD. |
|||
| 8:35-8:38 | Case presentation
Mohebbi B, MD. and Sadeghipour P, MD. |
|||
| 8:38-8:42 | Clinical Probability assessment
Bahadori MJ, MD. |
|||
| 8:42-8:46 | Risk Stratification
Salehi A, MD. |
|||
| 8:46-8:49 | RV/LV CT
Pouraliakbar HR, MD. |
|||
| 8:49-8:52 | Echocardiography
Farrashi M, MD. |
|||
| 8:52-8:55 | Outpatient vs Inpatient management
Nemati S, MD. |
|||
| 8:55-9:00 | Anticoagulation in PE, acute setting
Kakavand,H, MD. |
|||
| 9:00-9:06 | Why anticoagulation is not enough in Intermediate risk PE
Sadeghipour P, MD. |
|||
| 9:06-9:12 | Value of systemic thrombolytic regimens in PE
Rashidi F, MD. |
|||
| 9:12-9:22 | Catheter-based therapies in PE
Mohebbi B, MD. |
|||
| 9:22-9:32 | CDT in Practice
Mohebbi B, MD. and Sadeghipour P, MD. |
|||
| 9:32-9:35 | Choice of thrombolytic agent in CDT
Aghakouchakzadeh M, MD. |
|||
| 9:35-9:40 | RV recovery
Naderi N, MD. |
|||
| 9:40-9:45 | Surgical thrombectomy
Jadbabaie AN, MD. |
|||
| 9:45-10:00 | Panel Discussion | |||